Ccr9 Promotes Migration And Invasion Of Lung Adenocarcinoma Cancer Stem Cells
Lin Lu,Huan Du,Haowei Huang,Chenxi Wang,Peipei Wang,Zhiqiang Zha,Yong Wu,Xia Liu,Chengyin Weng,Xisheng Fang,Baoxiu Li,Haibo Mao,Lina Wang,Mingmei Guan,Guolong Liu
DOI: https://doi.org/10.7150/ijms.40864
2020-01-01
International Journal of Medical Sciences
Abstract:Aim: CC chemokine receptor 9 (CCR9) interacts with its exclusive ligand CCL25, resulting in promoting tumor progression and metastasis. However, the effect and mechanisms of CCR9 on lung adenocarcinoma distant metastasis remain largely unknown. To preliminary clarify the underlying mechanisms, we investigate the correlation between CCR9 and ALDH1A1(+)cancer stem cells (CSCs), as well as the effect of CCR9 on the migration and invasion of CSCs.Methods: Immunohistochemistry was performed to detect the expression of CCR9 in lung adenocarcinoma tissues. The correlations of CCR9 with distant metastasis and overall survival were investigated. Serial paraffin-embedded tissue blocks were used to detect ALDH1A1(+)CSCs expression. The correlations between CCR9 expression and ALDH1A1(+)CSCs were evaluated. We further studied the effect of CCR9/CCL25 on the migration and invasion of CSCs using transwell assays.Results: There were positive correlations between CCR9 expression and distant metastasis, as well as poor overall survival. Patients with high CCR9 expression were more likely to develop distant metastasis and demonstrated poorer overall survival than patients with low CCR9 expression. In addition, there was positive correlation between the expression of CCR9 and ALDH1A1 in the same tumor microenvironment. ALDH(high) CSCs demonstrated enhanced expression of CCR9 than ALDH(low) cells. Further transwell assays demonstrated that the numbers of CSCs migrated or invaded in response to CCL25 were more than that without CCL25 stimulation. Additional application of anti-CCR9 antibody reversed the CCL25-induced migration and invasion of CSCs.Conclusions: In summary, our study demonstrated that CCR9/CCL25 promoted the migration and invasion of CSCs, which might contribute to distant metastasis and poor overall survival. Our findings provided evidence that CCR9/CCL25 could be used as novel therapeutic targets for lung adenocarcinoma.